Efficacy of methyprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease

J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):510-1; author reply 511.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Humans
  • Incidence
  • Japan / epidemiology
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / pharmacology*
  • Methylprednisolone / therapeutic use*
  • Neuroleptic Malignant Syndrome / epidemiology*
  • Neuroleptic Malignant Syndrome / etiology*
  • Neuroprotective Agents / administration & dosage
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use*
  • Parkinson Disease / drug therapy*

Substances

  • Antiparkinson Agents
  • Neuroprotective Agents
  • Methylprednisolone